Private Advisor Group LLC Sells 3,299 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Private Advisor Group LLC cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 10.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 28,795 shares of the financial services provider’s stock after selling 3,299 shares during the quarter. Private Advisor Group LLC’s holdings in iShares Biotechnology ETF were worth $3,807,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter worth $30,000. HHM Wealth Advisors LLC grew its stake in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $138.91 on Monday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The business has a 50-day moving average price of $135.61 and a 200-day moving average price of $140.79.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.